394 related articles for article (PubMed ID: 11241230)
1. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements.
Faverly DR; Hendriks JH; Holland R
Cancer; 2001 Feb; 91(4):647-59. PubMed ID: 11241230
[TBL] [Abstract][Full Text] [Related]
2. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis.
Vicini FA; Kestin LL; Goldstein NS
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):722-30. PubMed ID: 15465188
[TBL] [Abstract][Full Text] [Related]
3. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ.
Lange M; Reimer T; Hartmann S; Glass Ä; Stachs A
Breast; 2016 Apr; 26():73-9. PubMed ID: 27017245
[TBL] [Abstract][Full Text] [Related]
4. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.
Pawlik TM; Perry A; Strom EA; Babiera GV; Buchholz TA; Singletary E; Perkins GH; Ross MI; Schecter NR; Meric-Bernstam F; Ames FC; Hunt KK; Kuerer HM
Cancer; 2004 Feb; 100(3):490-8. PubMed ID: 14745864
[TBL] [Abstract][Full Text] [Related]
5. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery.
Holland R; Veling SH; Mravunac M; Hendriks JH
Cancer; 1985 Sep; 56(5):979-90. PubMed ID: 2990668
[TBL] [Abstract][Full Text] [Related]
6. Comparison between high-resolution helical CT and pathology in breast examination.
Uematsu T; Sano M; Homma K; Sato N
Acta Radiol; 2002 Jul; 43(4):385-90. PubMed ID: 12225480
[TBL] [Abstract][Full Text] [Related]
7. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
8. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor.
Merrill AL; Coopey SB; Tang R; McEvoy MP; Specht MC; Hughes KS; Gadd MA; Smith BL
Ann Surg Oncol; 2016 Mar; 23(3):729-34. PubMed ID: 26467458
[TBL] [Abstract][Full Text] [Related]
9. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
10. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
[TBL] [Abstract][Full Text] [Related]
11. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy.
Moore MM; Borossa G; Imbrie JZ; Fechner RE; Harvey JA; Slingluff CL; Adams RB; Hanks JB
Ann Surg; 2000 Jun; 231(6):877-82. PubMed ID: 10816631
[TBL] [Abstract][Full Text] [Related]
12. Pre-treatment imaging and pathology characteristics of invasive breast cancers of limited extent: potential relevance for MRI-guided localized therapy.
Schmitz AC; Pengel KE; Loo CE; van den Bosch MA; Wesseling J; Gertenbach M; Alderliesten T; Mali WP; Rutgers EJ; Bartelink H; Gilhuijs KG
Radiother Oncol; 2012 Jul; 104(1):11-8. PubMed ID: 22652095
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
14. Margin width is not predictive of residual disease on re-excision in breast conserving therapy.
Hadzikadic Gusic L; McGuire KP; Ozmen T; Soran A; Thomas CR; McAuliffe PF; Diego EJ; Bonaventura M; Johnson RR; Ahrendt GM
J Surg Oncol; 2014 Apr; 109(5):426-30. PubMed ID: 24338603
[TBL] [Abstract][Full Text] [Related]
15. Conservative surgery for multifocal/multicentric breast cancer.
Nijenhuis MV; Rutgers EJ
Breast; 2015 Nov; 24 Suppl 2():S96-9. PubMed ID: 26303986
[TBL] [Abstract][Full Text] [Related]
16. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden.
Wazer DE; Schmidt-Ullrich RK; Schmid CH; Ruthazer R; Kramer B; Safaii H; Graham R
Int J Radiat Oncol Biol Phys; 1997 May; 38(2):291-9. PubMed ID: 9226315
[TBL] [Abstract][Full Text] [Related]
17. [Conservative therapy of I and II stage breast cancer--successful alternative to modified radical mastectomy].
Parvanova VM; Pandova VV; Garanina ZM
Vopr Onkol; 2001; 47(1):45-8. PubMed ID: 11317534
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of breast-conserving therapy for younger women with breast cancer.
Guenther JM; Kirgan DM; Giuliano AE
Arch Surg; 1996 Jun; 131(6):632-6. PubMed ID: 8645070
[TBL] [Abstract][Full Text] [Related]
19. Targeted Intraoperative Radiotherapy for the Management of Ductal Carcinoma In Situ of the Breast.
Rivera R; Banks A; Casillas-Lopez A; Rashtian A; Lewinsky B; Sheth P; Hovannesian-Larsen L; Brousseau D; Iyengar G; Holmes DR
Breast J; 2016; 22(1):63-74. PubMed ID: 26534876
[TBL] [Abstract][Full Text] [Related]
20. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
